将投中网设为"星标⭐"，第一时间收获最新推送 海淀如何做实全球AI产业高地。 作者丨 张雪 来源丨 投中网 2 月 28 日， 2026 海淀区经济社会高质量发展大会如约而至，从龙年到马年，这是海淀第三年召开 " 新春第一会 " ，也是 " 十五五 " 开局之年的 重要落子。 不同于之前谨慎克制的强基固本、产业升级，今年 " 新春第一会 " 一上来放出了多个大招，从顶层设计、政策驱动、机制创新、基金发布、产业落地 和全球合作等多角度、全方位进行了布局。 一个细节是，热闹最早从朋友圈传来。 28 日一大早，海淀的 " 新春第一会 " 就在朋友圈刷屏了，我随机问了几个创业者和投资人，他们对海淀新发 布的一系列政策王炸组合表示既兴奋又安心：这些动作足见海淀抢占科技高地的决心，同时又传递出在科技服务上的诚意。 再投 100 亿 其中，中关村科学城科技成长四期基金，总规模 80 亿元，这是在前三期的基础上再扩容，包括设立 70 亿元母基金，重点聚焦源头成果转化、联动重 点产业平台、合作市场白马机构；以及 10 亿元产业直投，锚定 "1+5+3" 产业体系，精准支持重点领域及产业链关键环节高成长项目。 最具价值投资之城实 ...

中新网广州2月25日电 (记者 王坚)广州市高质量发展大会25日在穗举行。会上，广州市科学技术局党组 书记、局长谢明称，广州将出台量子科技等赛道支持政策，布局建设脑机接口、高端科学仪器等领域类 国家技术创新中心，推动100个未来产业场景落地，争创国家未来产业先导区。 广州珠江两岸(资料图)。王坚 摄 谢明表示，将锚定建设科技创新强市目标，加强科技创新全领域布局。接下来，广州将推动产业科技互 促双强，夯实核心基础优势的同时，在提升战略引领"大科创"、提升产业能级、加速成果转化、完善创 新生态等方面重点发力。 谢明指出，推动产业科技互促双强，要继续发挥核心基础优势。要充分发挥"3+3+N"战略科技力量作 用，支持广州实验室建强建优，争创国家实验室基地，支持全国重点实验室优化升级，增强原始创新策 源功能。要加快集聚顶尖人才，持续实施"百万英才汇南粤"行动计划，2025年广州市新增五位"两院"院 士，国内首支省会城市国家自然科学基金联合基金实施一年来推动78人获得国家青年科学基金A、B类 项目，同比增长25%。 同时，要以建设国际科技创新中心重要承载地为目标，服务推动人体蛋白质组导航国际大科学计划实 施，发挥"一带一 ...

Group 1 - The "Huairou Science City Urban Living Room One-Stop Innovation Service Platform" has been launched to enhance the construction of the Huairou Comprehensive National Science Center, addressing common issues faced by innovation entities such as resource dispersion and information asymmetry [1] - The platform shifts the service model from "enterprises seeking services" to "services seeking enterprises," focusing on three core functionalities: service aggregation, intelligent precision, and efficient matching [1] - The platform integrates over 60 professional institutions, offering more than 230 high-frequency services covering the entire lifecycle of enterprises, including business, finance, intellectual property, and technology finance [1] Group 2 - Huairou Science City is evolving from a major technology infrastructure hub to an innovative community that deeply integrates basic research, technology breakthroughs, industrial transformation, and professional services [2] - By 2025, all 29 scientific facility platforms from the "13th Five-Year Plan" will be operational, with 17 facilities open to global users for a total of 1.64 million hours, accelerating the emergence of original innovative results [2] - The city is focusing on developing the high-end scientific instrument industry, with over 300 high-end instrument and sensor companies expected to establish operations during the "14th Five-Year Plan," including specialized "little giant" enterprises and high-tech companies [2]

Core Viewpoint - The article discusses the systematic regulation of government investment funds at the national level, aiming to direct substantial investments into sectors that struggle with resource allocation, particularly in high-tech industries like high-end scientific instruments, which represent "hard technology" [1][8]. Group 1: Policy Framework - The National Development and Reform Commission, Ministry of Finance, Ministry of Science and Technology, and Ministry of Industry and Information Technology jointly released the "Work Method for Strengthening the Layout Planning and Investment Guidance of Government Investment Funds (Trial)" [2]. - The "Management Method" establishes a comprehensive evaluation system for fund investment, combining quantitative and qualitative assessments to enhance policy guidance and management [2][8]. Group 2: Investment Focus Areas - The evaluation of fund investments will focus on supporting the development of new productive forces, with targeted sectors including new generation information technology, new energy, new materials, high-end equipment, new energy vehicles, green environmental protection, civil aviation, and marine engineering equipment [6]. - Future industries highlighted include areas such as metaverse, brain-computer interfaces, quantum information, humanoid robots, generative artificial intelligence, biomanufacturing, biological breeding, future displays, future networks, and new energy storage [7]. Group 3: Strategic Investment Guidelines - The "Work Method" outlines 14 policy measures focusing on "where to invest, how to invest, and who manages it" [8]. - It emphasizes the need for funds to support major strategies and key areas, particularly in sectors where market resource allocation is ineffective, promoting deep integration of technological and industrial innovation [8].

Core Viewpoint - Guoyi Quantum has successfully broken the foreign monopoly in high-end scientific instruments and is planning an IPO on the Sci-Tech Innovation Board to support the localization of high-end scientific instruments in China [1]. Group 1: Company Overview - Guoyi Quantum, established in December 2016, is recognized as a national-level specialized and innovative "little giant" enterprise and was included in the list of Chinese unicorn companies in 2024 [5]. - The company focuses on the research and development of high-end scientific instruments, providing essential equipment for quantum technology, materials science, chemical engineering, biomedicine, and advanced manufacturing [10]. - Guoyi Quantum has developed products that have broken the long-standing monopoly of international giants in certain segments of the domestic instrument market, achieving performance metrics that meet or exceed international competitors [10]. Group 2: Leadership and Control - The actual controllers of Guoyi Quantum are He Yu and Rong Xing, who collectively control 34.87% of the voting rights through various indirect holdings [3]. - He Yu, a notable figure from the University of Science and Technology of China (USTC), has held multiple leadership roles and has been recognized with various awards for his contributions to the industry [4]. - Rong Xing, also a USTC alumnus, has a distinguished academic background and has served in various significant positions within the scientific community [4]. Group 3: Financial Performance - Guoyi Quantum's revenue has shown significant growth, with figures of 151.45 million, 400 million, 501 million, and 171 million yuan for the years 2022 to 2025, reflecting year-on-year growth rates of 163.78% and 25.49% for 2023 and 2024 respectively [13]. - Despite the revenue growth, the company has not yet achieved profitability, with net losses reported at -168 million, -169 million, -104 million, and -74 million yuan for the same period [14]. - The company anticipates turning a profit in 2026, contingent on factors such as product strength, market expansion, and cost control [15]. Group 4: Market Position and Competition - The scientific instrument market has been dominated by international firms like Thermo Fisher, Danaher, and Agilent, which have established a strong presence over decades [16]. - Domestic manufacturers, including Guoyi Quantum, are gradually gaining recognition and breaking the monopoly of these international giants through technological advancements [16]. - Guoyi Quantum faces challenges in enhancing brand recognition and overcoming market penetration barriers due to the long-standing dominance of foreign brands [16][17].

Core Insights - The "Higher Education Regional Technology Transfer and Transformation Center (Guangdong-Hong Kong-Macao Greater Bay Area)" has been officially launched, marking the second such center established by the Ministry of Education after Jiangsu [1] Group 1: Center Establishment and Objectives - The center focuses on key areas such as biomedicine, intelligent transportation, and high-end scientific instruments, with plans to establish four sub-centers in Guangzhou and Shenzhen, aiming to create a total of 64 public transformation platforms within five years, with 21 currently under construction [2][4] - A transformation fund exceeding 10 billion yuan has been set up, along with over 800,000 square meters of space provided for concept validation and pilot testing, offering free support for entrepreneurial teams for three years [4] Group 2: Project Development and Collaboration - The center has connected with over 200 universities nationwide, gathering 1,500 high-quality technological achievements, and has formed a project reserve pool, with initial one-stop transformation services available [7] - The first batch of 27 high-level projects has been selected for transformation, sourced from prestigious institutions such as Tsinghua University, Fudan University, Hong Kong University of Science and Technology, and the University of Macau [5][7] Group 3: Addressing Challenges in Technology Transfer - The center aims to address multiple challenges faced by universities in transferring technology from laboratories to the market, focusing on building a comprehensive support system to resolve entrepreneurial pain points for faculty and students [8] - The center's initiatives include a specialized technology business school to train faculty on running enterprises and product development, transitioning from pure research to business-oriented models [10]

Group 1 - The Guangdong-Hong Kong-Macao Greater Bay Area has established the Regional Technology Transfer and Transformation Center, which aims to enhance technology transfer and innovation in the region [1] - The center has received approval from the Ministry of Education and includes four specific centers focused on various sectors such as biomedicine and intelligent transportation [1] - Over 200 leading universities are involved, with 57 signing cooperation agreements, including prestigious institutions like Fudan University and Tsinghua University [1] Group 2 - An Artificial Intelligence Open Alliance has been formed, led by Tsinghua University, with five specialized committees focusing on education, research, engineering, ethics, and international exchange [2] - The Life Sciences Open Alliance was established in 2025 in Hong Kong, involving 15 high-level universities and research institutions from mainland China and Hong Kong-Macao, aiming to foster innovation and international collaboration in life sciences [2] - A total of 10 projects and 20 guests signed agreements for industry-academia-research cooperation and significant technology transfer projects during the event [2]

Core Viewpoint - Guoyi Quantum Technology (Hefei) Co., Ltd. is seeking to go public on the Sci-Tech Innovation Board (STAR Market) and has recently had its IPO materials accepted by the exchange [1] Company Overview - Guoyi Quantum is focused on the research and development of high-end scientific instruments, providing equipment and solutions for various fields including quantum technology, materials science, chemical engineering, biomedicine, and advanced manufacturing [5] - The company has delivered products to over 80 985/211 universities and more than 150 research institutes, with notable clients including Tsinghua University, Peking University, and industry leaders like BOE, BYD, and CATL [5] Leadership and Shareholding - The company is controlled by He Yu and Rong Xing, who together hold 34.87% of the voting rights. He Yu serves as the Chairman and General Manager, while Rong Xing is a board member [1][3] - He Yu's salary for 2024 is reported to be 692,800 yuan, which is relatively low compared to other executives [4] - Hillhouse Capital is a significant shareholder, holding 22,044,400 shares, which accounts for 6.12% of the total share capital before the IPO [4] Financial Performance - The company's projected revenues from 2022 to the first half of 2025 are 151 million yuan, 400 million yuan, 501 million yuan, and 171 million yuan, respectively. The net profit after deducting non-recurring items is expected to be negative for all periods, with figures of -168 million yuan, -169 million yuan, -104 million yuan, and -73.94 million yuan [5] - The company plans to raise 1.169 billion yuan through its IPO [6]

Core Viewpoint - Guoyi Quantum Technology (Hefei) Co., Ltd. is planning to go public on the Sci-Tech Innovation Board, with rapid revenue growth but has not yet achieved profitability [1][4]. Group 1: Company Overview - Guoyi Quantum was established in 2016 and focuses on the research and development of high-end scientific instruments, providing essential equipment and solutions for quantum technology, materials science, chemical engineering, biomedical fields, and more [2]. - The company's actual controllers are He Yu and Rong Xing, who indirectly control 34.87% of the voting rights through various entities [2]. Group 2: Financial Performance - The company has shown significant revenue growth, with a compound annual growth rate (CAGR) of 81.94% from 2022 to 2024, although it has incurred losses during this period [4][7]. - Revenue figures for the years 2022 to 2025 (first half) are as follows: 151.50 million, 399.62 million, 501.47 million, and 171.21 million [4]. - The company expects to narrow its net profit loss significantly by 2025 and potentially achieve profitability by 2026 [7]. Group 3: Customer Base and Market Challenges - The customer base is relatively dispersed, with the top five customers contributing a decreasing percentage of total revenue from 26.62% in 2022 to 13.41% in the first half of 2025 [8][11]. - The high unit price and long lifespan of the products (5 to 10 years) result in low short-term repurchase rates from the same customers, complicating market expansion and customer maintenance [11]. - The industry is highly competitive, with established international firms holding significant market share, posing challenges for Guoyi Quantum in terms of brand recognition and product performance [11].

Core Viewpoint - The establishment of regional technology transfer centers in the Guangdong-Hong Kong-Macao Greater Bay Area aims to enhance the conversion of scientific research achievements from universities into industrial applications, particularly in the fields of biomedicine, intelligent transportation, and high-end scientific instruments. Group 1: Intelligent Transportation Sub-center - The Intelligent Transportation Sub-center has been approved and is located in Guangzhou University Town, focusing on integrating education, technology, and talent development [5] - The center aims to leverage Guangzhou's trillion-level new energy vehicle industry cluster and leading low-altitude economy to accelerate the transformation of research achievements into productive forces [5][6] - Currently, the center has engaged with 40 universities, collected 364 projects, and selected 65 quality projects, with 17 projects from various universities already established [6][7] Group 2: High-end Scientific Instruments Sub-center - The High-end Scientific Instruments Sub-center aims to address the low conversion rate of scientific achievements in universities and reduce reliance on imported high-end scientific instruments [8] - The center is building nine common technology platforms and three shared platforms to facilitate resource sharing and inject new momentum into the industry [8][9] - A phased funding model is being implemented, providing up to 1 million yuan for concept validation and up to 10 million yuan for industrial transformation for successful projects [8][9] Group 3: Biomedicine Sub-center - The Biomedicine Sub-center was established in August and is located on the International Biological Island in Guangzhou, which hosts over 530 biomedicine innovation companies [10] - The center focuses on cutting-edge areas such as "cell gene" and "AI + pharmaceuticals," aiming to solve the challenges of converting biomedicine research into practical applications [10] - Currently, 159 projects have been preliminarily selected for entry into the center, focusing on "cell gene therapy" and "AI pharmaceuticals" [10]